Helmholtz-Zentrum Berlin joins OMA as Adjunct Partner
Helmholtz-Zentrum Berlin (HZB) has become the latest member of the OMA family after the Steering Committee accepted unanimously their request for admission as an adjunct partner.
The Proton Therapy group at HZB, led by Prof Dr Andrea Denker, is routinely treating eye tumours with a 70-MeV cyclotron in collaboration with the Charité hospital in Berlin, where they have treated more than 4,000 patients so far with 97% tumour control.
The proton irradiation centre at the HZB is Germany's first proton therapy facility and unique in its technical capability.
Their current R&D activities focus on FLASH studies, mixed/cocktail ion beams, dosimetry, minibeam therapy and developing a dedicated cyclotron for eye tumours.
The partnership of HZB with OMA will open the possibility to establish new collaborations and research activities.
Welcome!